StockData
Spero Therapeutics, Inc. logo

Spero Therapeutics, Inc. (SPRO) stock

SPRONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3042% below fair value
$0.90−0.05 (-4.77%)

Close on Nov 17, 2026Market cap $52.49MP/E 22.5Yield –

Spero Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Spero Therapeutics

Spero Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Spero Therapeutics figures

See a number that looks wrong?